Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD

Inhaled fixed-dose combinations (FDCs) of a long-acting β-agonist (LABA) and a long-acting muscarinic antagonist (LAMA) have become the cornerstone for the maintenance treatment of symptomatic COPD patients. In this regard, global COPD treatment guidelines have recognized the importance of inhaler d...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Urzo, Anthony, Chapman, Kenneth R., Donohue, James F., Kardos, Peter, Maleki-Yazdi, M. Reza, Price, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967354/
https://www.ncbi.nlm.nih.gov/pubmed/32026426
http://dx.doi.org/10.1007/s41030-019-0090-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967354/
https://www.ncbi.nlm.nih.gov/pubmed/32026426
http://dx.doi.org/10.1007/s41030-019-0090-1

Ejemplares similares